The value of comparative effectiveness research: projected return on investment of the RxPONDER trial (SWOG S1007)
about
Prospective Validation of a 21-Gene Expression Assay in Breast CancerIntegrating comparative effectiveness design elements and endpoints into a phase III, randomized clinical trial (SWOG S1007) evaluating oncotypeDX-guided management for women with breast cancer involving lymph nodes.Adoption of Gene Expression Profiling for Breast Cancer in US Oncology Practice for Women Younger Than 65 Years.Improving early cycle economic evaluation of diagnostic technologies.News on the medical treatment of young women with early-stage HER2-negative breast cancer.Development and Evaluation of an Approach to Using Value of Information Analyses for Real-Time Prioritization Decisions Within SWOG, a Large Cancer Clinical Trials Cooperative Group.ONCOLOGISTS' BARRIERS AND FACILITATORS FOR ONCOTYPE DX USE: QUALITATIVE STUDY.Learning from big data: are we undertreating older women with high-risk breast cancer?Breast cancer-specific survival in patients with lymph node-positive hormone receptor-positive invasive breast cancer and Oncotype DX Recurrence Score results in the SEER database.
P2860
Q29011698-12EEC6A2-F217-4C52-AB43-A64D67FE2187Q36476471-734D3E23-B5B1-4CC3-B440-8749B1A76668Q37151779-DF0D2A69-3CDD-4FCA-9D02-F581EC1DBBE1Q38207115-1308C065-FC72-4CAA-92F0-EC38DA84E347Q38870541-ADCE73B8-ADA1-4548-9B6D-FA42622F629EQ38890570-BECB2631-0F9F-4524-BAE1-A11CA21049B0Q39106167-22906D85-AE39-4BE4-B46C-55A6B1D214EFQ42334187-923B05B6-DCDD-4333-963A-B14E8CC0CCABQ50869231-CD2B5F14-5596-4FD6-9957-58315EFF335F
P2860
The value of comparative effectiveness research: projected return on investment of the RxPONDER trial (SWOG S1007)
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
The value of comparative effec ...... he RxPONDER trial (SWOG S1007)
@ast
The value of comparative effec ...... he RxPONDER trial (SWOG S1007)
@en
type
label
The value of comparative effec ...... he RxPONDER trial (SWOG S1007)
@ast
The value of comparative effec ...... he RxPONDER trial (SWOG S1007)
@en
prefLabel
The value of comparative effec ...... he RxPONDER trial (SWOG S1007)
@ast
The value of comparative effec ...... he RxPONDER trial (SWOG S1007)
@en
P2093
P2860
P1476
The value of comparative effec ...... he RxPONDER trial (SWOG S1007)
@en
P2093
David L Veenstra
Louis P Garrison
Scott D Ramsey
William E Barlow
P2860
P304
P356
10.1016/J.CCT.2012.08.006
P407
P50
P577
2012-08-18T00:00:00Z